Reported Standalone quarterly numbers for Sun Pharma Advanced Research Company are:
Net Sales at Rs 62.15 crore in December 2021 up 184.96% from Rs. 21.81 crore in December 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 15.84 crore in December 2021 up 76.57% from Rs. 67.62 crore in December 2020.
EBITDA stands negative at Rs. 10.93 crore in December 2021 up 82.19% from Rs. 61.36 crore in December 2020.
Sun Pharma Adv shares closed at 325.70 on February 07, 2022 (NSE) and has given 14.62% returns over the last 6 months and 71.42% over the last 12 months.
Story continues below Advertisement
| Sun Pharma Advanced Research Company | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 62.15 | 27.87 | 21.81 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 62.15 | 27.87 | 21.81 | | EXPENDITURE | | Consumption of Raw Materials | 3.67 | 5.35 | 5.59 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 24.24 | 23.94 | 22.65 | | Depreciation | 2.58 | 2.54 | 2.76 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 45.51 | 53.75 | 56.53 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -13.85 | -57.71 | -65.72 | | Other Income | 0.34 | 5.98 | 1.60 | | P/L Before Int., Excpt. Items & Tax | -13.51 | -51.73 | -64.12 | | Interest | 2.33 | 3.41 | 3.50 | | P/L Before Exceptional Items & Tax | -15.84 | -55.14 | -67.62 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.84 | -55.14 | -67.62 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -15.84 | -55.14 | -67.62 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -15.84 | -55.14 | -67.62 | | Equity Share Capital | 26.35 | 26.35 | 26.21 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.60 | -2.09 | -2.58 | | Diluted EPS | -0.60 | -2.09 | -2.58 | | EPS After Extra Ordinary | | Basic EPS | -0.60 | -2.09 | -2.58 | | Diluted EPS | -0.60 | -2.09 | -2.58 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
